Response Letter to the Editor: "Expanding eligibility for intracranial electroencephalography using dexmedetomidine hydrochloride in children with behavioral dyscontrol"

Epilepsy Behav. 2024 Apr:153:109657. doi: 10.1016/j.yebeh.2024.109657. Epub 2024 Feb 17.

Authors

Thomas Johnstone¹, Maria Isabel Barros Guinle¹, Gerald A Grant², Brenda E Porter³

Affiliations

¹ Stanford University School of Medicine, United States.
² Department of Neurosurgery, Duke University School of Medicine, United States.
³ Department of Neurology and Neurological Sciences Stanford, Division of Child Neurology, Lucile Packard Children's Hospital, United States. Electronic address: brenda2@stanford.edu.

PMID: 38368786
DOI: 10.1016/j.yebeh.2024.109657

No abstract available

Publication types

Letter

MeSH terms

Child
Dexmedetomidine* / therapeutic use
Electrocorticography
Electroencephalography
Humans
Hypnotics and Sedatives

Substances

Dexmedetomidine
Hypnotics and Sedatives